Back to search
Verified
Government
Health
Ryplle ID RYP-0650Last checked Oct 28, 2026

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

National Institutes of Health

Funding range
$0 – $6M
Application window
Opens: Not listed
Closes: December 1, 2030
Applications Status:Upcoming
Location
National
Apply on funder's site

Source & verification

Original funding source
www.grants.gov
Last checked
October 28, 2026
Last reviewed by Ryplle
Not yet recorded

Source checks may be automated. Review dates reflect a recorded staff review. Confirm current requirements with the funder.

Eligibility at a glance

Listed applicant types
Student, Nonprofit, Business
Geographic eligibility
National
Matching funds
Not specified — check with the funder
Major exclusions
Not specified — check with the funder

Listed types are not a determination of eligibility. The funder’s full requirements take precedence.

Full eligibility requirements

Eligible applicants: Public and State controlled institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; County governments; Native American tribal organizations (other than Federally recognized tribal governments); Private institutions of higher education; City or township governments; Independent school districts; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Public housing authorities/Indian housing authorities; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); Special district governments.

About this grant

This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.

Contact information